BRAINSTORM CELL THERAPEUTICS INC. Operating Loss Carryforwards
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Operating Loss Carryforwards of $231.87 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-03-31
- 2025-12-31: Operating Loss Carryforwards $231.87M.
- 2024-12-31: Operating Loss Carryforwards $201.26M.
- 2023-12-31: Operating Loss Carryforwards $182.49M.
- 2022-12-31: Operating Loss Carryforwards $155.31M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $231.87M 10-K · filed 2026-03-31 |
| 2024-12-31 | $201.26M 10-K · filed 2026-03-31 |
| 2023-12-31 | $182.49M 10-K · filed 2025-03-31 |
| 2022-12-31 | $155.31M 10-K · filed 2024-04-01 |
| 2021-12-31 | $126.80M 10-K · filed 2023-03-30 |
| 2020-12-31 | $99.82M 10-K · filed 2022-03-28 |
| 2019-12-31 | $73.26M 10-K · filed 2021-02-04 |
| 2018-12-31 | $57.77M 10-K · filed 2020-02-18 |
| 2017-12-31 | $51.11M 10-K · filed 2019-04-01 |
| 2016-12-31 | $39.97M 10-K · filed 2018-03-08 |
| 2015-12-31 | $34.67M 10-K · filed 2017-03-29 |
| 2014-12-31 | $29.22M 10-K · filed 2016-03-09 |
| 2013-12-31 | $25.16M 10-K · filed 2015-03-26 |
| 2012-12-31 | $22.07M 10-K · filed 2014-03-27 |
| 2011-12-31 | $19.70M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |